Board of Trustees of The Leland Stanford Junior University’s Lucira Health, Inc. Common Stock LHDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-124,459
Closed -$946K 50
2021
Q3
$946K Sell
124,459
-252,246
-67% -$2.13M 0.07% 25
2021
Q2
$2.5M Hold
376,705
0.23% 18
2021
Q1
$4.56M Buy
+376,705
New +$7.47M 0.4% 12

Other funds holding LHDX

Board of Trustees of The Leland Stanford Junior University's LHDX Position: Q4 2021 in Review

Board of Trustees of The Leland Stanford Junior University sold out of Lucira Health, Inc. Common Stock (LHDX) in Q4 2021, closing a stake of 124,459 shares — an estimated $946K sold.

Board of Trustees of The Leland Stanford Junior University first reported a position in LHDX in Q1 2021 and held it in 3 quarters. The position peaked at $4.56M in Q1 2021. 46 funds tracked by Wall St. Rank hold LHDX as of Q4 2021.

  • Board of Trustees of The Leland Stanford Junior University reported no remaining Lucira Health, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • Board of Trustees of The Leland Stanford Junior University sold 124,459 Lucira Health, Inc. Common Stock shares in Q4 2021, an estimated $946K.
  • Board of Trustees of The Leland Stanford Junior University first reported a position in Lucira Health, Inc. Common Stock in Q1 2021 and held it in 3 quarters.
  • Board of Trustees of The Leland Stanford Junior University's Lucira Health, Inc. Common Stock position peaked at $4.56M in Q1 2021.
  • 46 funds tracked by Wall St. Rank held Lucira Health, Inc. Common Stock as of Q4 2021.

Based on Board of Trustees of The Leland Stanford Junior University's 13F filing for Q4 2021, filed 14 Feb 2022.